04/09/2024
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
8:06 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
3:45 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:55 PM | Agile Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
3:57 PM | Agile Therapeutics (Filer)
| Form 424B5 | |
02/15/2024
3:45 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/13/2024
7:02 PM | Agile Therapeutics (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
02/06/2024
9:14 AM | Agile Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024
8:21 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
12/20/2023
7:00 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
12/11/2023
4:30 PM | Agile Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/06/2023
7:00 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
7:00 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:15 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:45 PM | Agile Therapeutics (Issuer)
Coiante Scott M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:30 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
3:50 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K/A | |
08/09/2023
7:10 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:50 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:36 PM | Agile Therapeutics (Issuer)
Gilmore Geoffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:37 PM | Agile Therapeutics (Issuer)
Conway Robert G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:37 PM | Agile Therapeutics (Issuer)
ALTOMARI ALFRED (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:38 PM | Agile Therapeutics (Issuer)
Korner Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:38 PM | Agile Therapeutics (Issuer)
Welsh Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
3:46 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:35 PM | Agile Therapeutics (Filer)
| Form 8-K/A | |
06/09/2023
4:08 PM | Agile Therapeutics (Issuer)
BARBARI SHARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:09 PM | Agile Therapeutics (Issuer)
Carson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:10 PM | Agile Therapeutics (Issuer)
Hubbard John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:12 PM | Agile Therapeutics (Issuer)
Fischer Seth H. Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:13 PM | Agile Therapeutics (Issuer)
Torrente Josephine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:19 PM | Agile Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2023
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
4:25 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
11:27 AM | Agile Therapeutics (Filer)
| Form 424B5 | |
05/25/2023
11:29 AM | Agile Therapeutics (Filer)
| Form 424B5 | |
05/25/2023
11:25 AM | Agile Therapeutics (Filer)
| Form 424B5 | |
05/24/2023
3:05 PM | Agile Therapeutics (Filer)
| Form 424B4 | |
05/22/2023
11:15 PM | Agile Therapeutics (Filer)
| Form EFFECT | |
55x Gains Instead of 9x Gains (Ad) We’ve issued an urgent landmark trade alert for a new crypto wonder.
So, I decided to give you this heads-up before it’s too late.
It’s urgent because it’s what we consider “The #1 Crypto for the AI World.” Learn more about it by watching THIS NOW. |
05/19/2023
11:20 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
05/17/2023
6:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
